Study of a new pain medicine for arm or leg injuries in the ER
Part of Brain & nervous system, Pain clinical trials.
This trial tests a fast-acting pain pill (sufentanil) placed under the tongue for people with moderate to severe pain from a single arm or leg injury. It aims to see if it works well in the emergency room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have pain from one arm or leg injury rated 4 or higher on a 0–10 scale
- You are awake and alert (Glasgow Coma Scale = 15)
- Your oxygen level is above 95% while breathing room air
- You have not taken any pain medicine (except Tylenol) in the 4 hours before arriving to the ER
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different nasal sprays (sufentanil vs ketamine) to quickly relieve severe pain from a recent arm or leg injury in children. It aims to find which works better and is safer.
This trial tests if a liquid form of ketamine works as well as a common opioid (oxycodone) for treating pain in the emergency department. If you have arm, leg, back, or neck pain that isn't controlled by first treatments, you may be able to join.
This trial looks at how well a pain-control plan works after certain orthopedic surgeries and how it affects recovery and patient-reported outcomes. It may help determine what level of pain relief is meaningful to patients after surgery.
This trial tests whether paramedics can safely give a strong painkiller (sufentanil) to adults with severe pain from a recent injury. It aims to see if it works well and is safe when given in the field.
This trial tests whether a new under-the-tongue pain medication (sublingual sufentanil) helps people recover better after surgery compared to standard oral pain relief. You'll be randomly assigned to receive either this new medication or a traditional pain reliever when you need it after your operation.
This trial tests a fentanyl-like nose spray (sufentanil) to relieve severe pain from a sickle cell crisis in children and teens. It aims to see if it works better than usual pain treatments.
Hear when a new Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.